The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Genital Herpes Treatment Drug Market Research Report 2025

Global Genital Herpes Treatment Drug Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1730768

No of Pages : 97

Ask Your Query

Synopsis
Highlights
The global Genital Herpes Treatment Drug market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
The major global companies of Genital Herpes Treatment Drug include Fresenius Kabi, Avet Pharmaceuticals Inc., Carlsbad Tech, Glenmark Pharmaceuticals Inc., Zydus Pharmaceuticals, Mylan Pharmaceutcials Inc., Apotex Inc., Epi Health LLC and AiCuris Anti-infective Cures GmbH, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Acyclovir (Zovirax), which accounted for % of the global market of Genital Herpes Treatment Drug in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Genital Herpes Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genital Herpes Treatment Drug.
The Genital Herpes Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Genital Herpes Treatment Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genital Herpes Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Some of the prominent players reviewed in the research report include:

  • Fresenius Kabi
  • Avet Pharmaceuticals Inc.
  • Carlsbad Tech
  • Glenmark Pharmaceuticals Inc.
  • Zydus Pharmaceuticals
  • Mylan Pharmaceutcials Inc.
  • Apotex Inc.
  • Epi Health LLC
  • AiCuris Anti-infective Cures GmbH
  • Chimerix
  • Admedus
  • Sanofi Pasteur SA
  • Maruho Co. Ltd.
  • F.Hoffmann-La Roche Ltd.
  • Novartis AG
  • Merck & Co. Inc.
  • GlaxoSmithKline Plc

Product Type Insights
Global markets are presented by Genital Herpes Treatment Drug type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Genital Herpes Treatment Drug are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Genital Herpes Treatment Drug segment by Type

  • Acyclovir (Zovirax)
  • Famciclovir (Famvir)
  • Valacyclovir (Valtrex)
  • Others

Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Genital Herpes Treatment Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Genital Herpes Treatment Drug market.

Genital Herpes Treatment Drug Segment by Application

  • Hospital
  • Clinic
  • Others

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Genital Herpes Treatment Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genital Herpes Treatment Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Genital Herpes Treatment Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Genital Herpes Treatment Drug industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genital Herpes Treatment Drug.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genital Herpes Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genital Herpes Treatment Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Acyclovir (Zovirax)
1.2.3 Famciclovir (Famvir)
1.2.4 Valacyclovir (Valtrex)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Genital Herpes Treatment Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genital Herpes Treatment Drug Market Perspective (2017-2028)
2.2 Genital Herpes Treatment Drug Growth Trends by Region
2.2.1 Genital Herpes Treatment Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Genital Herpes Treatment Drug Historic Market Size by Region (2017-2022)
2.2.3 Genital Herpes Treatment Drug Forecasted Market Size by Region (2023-2028)
2.3 Genital Herpes Treatment Drug Market Dynamics
2.3.1 Genital Herpes Treatment Drug Industry Trends
2.3.2 Genital Herpes Treatment Drug Market Drivers
2.3.3 Genital Herpes Treatment Drug Market Challenges
2.3.4 Genital Herpes Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genital Herpes Treatment Drug Players by Revenue
3.1.1 Global Top Genital Herpes Treatment Drug Players by Revenue (2017-2022)
3.1.2 Global Genital Herpes Treatment Drug Revenue Market Share by Players (2017-2022)
3.2 Global Genital Herpes Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genital Herpes Treatment Drug Revenue
3.4 Global Genital Herpes Treatment Drug Market Concentration Ratio
3.4.1 Global Genital Herpes Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genital Herpes Treatment Drug Revenue in 2021
3.5 Genital Herpes Treatment Drug Key Players Head office and Area Served
3.6 Key Players Genital Herpes Treatment Drug Product Solution and Service
3.7 Date of Enter into Genital Herpes Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genital Herpes Treatment Drug Breakdown Data by Type
4.1 Global Genital Herpes Treatment Drug Historic Market Size by Type (2017-2022)
4.2 Global Genital Herpes Treatment Drug Forecasted Market Size by Type (2023-2028)
5 Genital Herpes Treatment Drug Breakdown Data by Application
5.1 Global Genital Herpes Treatment Drug Historic Market Size by Application (2017-2022)
5.2 Global Genital Herpes Treatment Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genital Herpes Treatment Drug Market Size (2017-2028)
6.2 North America Genital Herpes Treatment Drug Market Size by Country (2017-2022)
6.3 North America Genital Herpes Treatment Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Genital Herpes Treatment Drug Market Size (2017-2028)
7.2 Europe Genital Herpes Treatment Drug Market Size by Country (2017-2022)
7.3 Europe Genital Herpes Treatment Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genital Herpes Treatment Drug Market Size (2017-2028)
8.2 Asia-Pacific Genital Herpes Treatment Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Genital Herpes Treatment Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Genital Herpes Treatment Drug Market Size (2017-2028)
9.2 Latin America Genital Herpes Treatment Drug Market Size by Country (2017-2022)
9.3 Latin America Genital Herpes Treatment Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genital Herpes Treatment Drug Market Size (2017-2028)
10.2 Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Fresenius Kabi
11.1.1 Fresenius Kabi Company Detail
11.1.2 Fresenius Kabi Business Overview
11.1.3 Fresenius Kabi Genital Herpes Treatment Drug Introduction
11.1.4 Fresenius Kabi Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.1.5 Fresenius Kabi Recent Development
11.2 Avet Pharmaceuticals Inc.
11.2.1 Avet Pharmaceuticals Inc. Company Detail
11.2.2 Avet Pharmaceuticals Inc. Business Overview
11.2.3 Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Introduction
11.2.4 Avet Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.2.5 Avet Pharmaceuticals Inc. Recent Development
11.3 Carlsbad Tech
11.3.1 Carlsbad Tech Company Detail
11.3.2 Carlsbad Tech Business Overview
11.3.3 Carlsbad Tech Genital Herpes Treatment Drug Introduction
11.3.4 Carlsbad Tech Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.3.5 Carlsbad Tech Recent Development
11.4 Glenmark Pharmaceuticals Inc.
11.4.1 Glenmark Pharmaceuticals Inc. Company Detail
11.4.2 Glenmark Pharmaceuticals Inc. Business Overview
11.4.3 Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Introduction
11.4.4 Glenmark Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.4.5 Glenmark Pharmaceuticals Inc. Recent Development
11.5 Zydus Pharmaceuticals
11.5.1 Zydus Pharmaceuticals Company Detail
11.5.2 Zydus Pharmaceuticals Business Overview
11.5.3 Zydus Pharmaceuticals Genital Herpes Treatment Drug Introduction
11.5.4 Zydus Pharmaceuticals Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.5.5 Zydus Pharmaceuticals Recent Development
11.6 Mylan Pharmaceutcials Inc.
11.6.1 Mylan Pharmaceutcials Inc. Company Detail
11.6.2 Mylan Pharmaceutcials Inc. Business Overview
11.6.3 Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Introduction
11.6.4 Mylan Pharmaceutcials Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.6.5 Mylan Pharmaceutcials Inc. Recent Development
11.7 Apotex Inc.
11.7.1 Apotex Inc. Company Detail
11.7.2 Apotex Inc. Business Overview
11.7.3 Apotex Inc. Genital Herpes Treatment Drug Introduction
11.7.4 Apotex Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.7.5 Apotex Inc. Recent Development
11.8 Epi Health LLC
11.8.1 Epi Health LLC Company Detail
11.8.2 Epi Health LLC Business Overview
11.8.3 Epi Health LLC Genital Herpes Treatment Drug Introduction
11.8.4 Epi Health LLC Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.8.5 Epi Health LLC Recent Development
11.9 AiCuris Anti-infective Cures GmbH
11.9.1 AiCuris Anti-infective Cures GmbH Company Detail
11.9.2 AiCuris Anti-infective Cures GmbH Business Overview
11.9.3 AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Introduction
11.9.4 AiCuris Anti-infective Cures GmbH Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.9.5 AiCuris Anti-infective Cures GmbH Recent Development
11.10 Chimerix
11.10.1 Chimerix Company Detail
11.10.2 Chimerix Business Overview
11.10.3 Chimerix Genital Herpes Treatment Drug Introduction
11.10.4 Chimerix Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.10.5 Chimerix Recent Development
11.11 Admedus
11.11.1 Admedus Company Detail
11.11.2 Admedus Business Overview
11.11.3 Admedus Genital Herpes Treatment Drug Introduction
11.11.4 Admedus Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.11.5 Admedus Recent Development
11.12 Sanofi Pasteur SA
11.12.1 Sanofi Pasteur SA Company Detail
11.12.2 Sanofi Pasteur SA Business Overview
11.12.3 Sanofi Pasteur SA Genital Herpes Treatment Drug Introduction
11.12.4 Sanofi Pasteur SA Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.12.5 Sanofi Pasteur SA Recent Development
11.13 Maruho Co. Ltd.
11.13.1 Maruho Co. Ltd. Company Detail
11.13.2 Maruho Co. Ltd. Business Overview
11.13.3 Maruho Co. Ltd. Genital Herpes Treatment Drug Introduction
11.13.4 Maruho Co. Ltd. Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.13.5 Maruho Co. Ltd. Recent Development
11.14 F.Hoffmann-La Roche Ltd.
11.14.1 F.Hoffmann-La Roche Ltd. Company Detail
11.14.2 F.Hoffmann-La Roche Ltd. Business Overview
11.14.3 F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Introduction
11.14.4 F.Hoffmann-La Roche Ltd. Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.14.5 F.Hoffmann-La Roche Ltd. Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Detail
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Genital Herpes Treatment Drug Introduction
11.15.4 Novartis AG Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.15.5 Novartis AG Recent Development
11.16 Merck & Co. Inc.
11.16.1 Merck & Co. Inc. Company Detail
11.16.2 Merck & Co. Inc. Business Overview
11.16.3 Merck & Co. Inc. Genital Herpes Treatment Drug Introduction
11.16.4 Merck & Co. Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.16.5 Merck & Co. Inc. Recent Development
11.17 GlaxoSmithKline Plc
11.17.1 GlaxoSmithKline Plc Company Detail
11.17.2 GlaxoSmithKline Plc Business Overview
11.17.3 GlaxoSmithKline Plc Genital Herpes Treatment Drug Introduction
11.17.4 GlaxoSmithKline Plc Revenue in Genital Herpes Treatment Drug Business (2017-2022)
11.17.5 GlaxoSmithKline Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Genital Herpes Treatment Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Acyclovir (Zovirax)
Table 3. Key Players of Famciclovir (Famvir)
Table 4. Key Players of Valacyclovir (Valtrex)
Table 5. Key Players of Others
Table 6. Global Genital Herpes Treatment Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Genital Herpes Treatment Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Genital Herpes Treatment Drug Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Genital Herpes Treatment Drug Market Share by Region (2017-2022)
Table 10. Global Genital Herpes Treatment Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Genital Herpes Treatment Drug Market Share by Region (2023-2028)
Table 12. Genital Herpes Treatment Drug Market Trends
Table 13. Genital Herpes Treatment Drug Market Drivers
Table 14. Genital Herpes Treatment Drug Market Challenges
Table 15. Genital Herpes Treatment Drug Market Restraints
Table 16. Global Genital Herpes Treatment Drug Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Genital Herpes Treatment Drug Market Share by Players (2017-2022)
Table 18. Global Top Genital Herpes Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drug as of 2021)
Table 19. Ranking of Global Top Genital Herpes Treatment Drug Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Genital Herpes Treatment Drug Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Genital Herpes Treatment Drug Product Solution and Service
Table 23. Date of Enter into Genital Herpes Treatment Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Genital Herpes Treatment Drug Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Genital Herpes Treatment Drug Revenue Market Share by Type (2017-2022)
Table 27. Global Genital Herpes Treatment Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Genital Herpes Treatment Drug Revenue Market Share by Type (2023-2028)
Table 29. Global Genital Herpes Treatment Drug Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Genital Herpes Treatment Drug Revenue Market Share by Application (2017-2022)
Table 31. Global Genital Herpes Treatment Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Genital Herpes Treatment Drug Revenue Market Share by Application (2023-2028)
Table 33. North America Genital Herpes Treatment Drug Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Genital Herpes Treatment Drug Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Genital Herpes Treatment Drug Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Genital Herpes Treatment Drug Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Genital Herpes Treatment Drug Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Genital Herpes Treatment Drug Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Genital Herpes Treatment Drug Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Genital Herpes Treatment Drug Market Size by Country (2023-2028) & (US$ Million)
Table 43. Fresenius Kabi Company Detail
Table 44. Fresenius Kabi Business Overview
Table 45. Fresenius Kabi Genital Herpes Treatment Drug Product
Table 46. Fresenius Kabi Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 47. Fresenius Kabi Recent Development
Table 48. Avet Pharmaceuticals Inc. Company Detail
Table 49. Avet Pharmaceuticals Inc. Business Overview
Table 50. Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Product
Table 51. Avet Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 52. Avet Pharmaceuticals Inc. Recent Development
Table 53. Carlsbad Tech Company Detail
Table 54. Carlsbad Tech Business Overview
Table 55. Carlsbad Tech Genital Herpes Treatment Drug Product
Table 56. Carlsbad Tech Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 57. Carlsbad Tech Recent Development
Table 58. Glenmark Pharmaceuticals Inc. Company Detail
Table 59. Glenmark Pharmaceuticals Inc. Business Overview
Table 60. Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Product
Table 61. Glenmark Pharmaceuticals Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 62. Glenmark Pharmaceuticals Inc. Recent Development
Table 63. Zydus Pharmaceuticals Company Detail
Table 64. Zydus Pharmaceuticals Business Overview
Table 65. Zydus Pharmaceuticals Genital Herpes Treatment Drug Product
Table 66. Zydus Pharmaceuticals Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 67. Zydus Pharmaceuticals Recent Development
Table 68. Mylan Pharmaceutcials Inc. Company Detail
Table 69. Mylan Pharmaceutcials Inc. Business Overview
Table 70. Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Product
Table 71. Mylan Pharmaceutcials Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 72. Mylan Pharmaceutcials Inc. Recent Development
Table 73. Apotex Inc. Company Detail
Table 74. Apotex Inc. Business Overview
Table 75. Apotex Inc. Genital Herpes Treatment Drug Product
Table 76. Apotex Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 77. Apotex Inc. Recent Development
Table 78. Epi Health LLC Company Detail
Table 79. Epi Health LLC Business Overview
Table 80. Epi Health LLC Genital Herpes Treatment Drug Product
Table 81. Epi Health LLC Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 82. Epi Health LLC Recent Development
Table 83. AiCuris Anti-infective Cures GmbH Company Detail
Table 84. AiCuris Anti-infective Cures GmbH Business Overview
Table 85. AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Product
Table 86. AiCuris Anti-infective Cures GmbH Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 87. AiCuris Anti-infective Cures GmbH Recent Development
Table 88. Chimerix Company Detail
Table 89. Chimerix Business Overview
Table 90. Chimerix Genital Herpes Treatment Drug Product
Table 91. Chimerix Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 92. Chimerix Recent Development
Table 93. Admedus Company Detail
Table 94. Admedus Business Overview
Table 95. Admedus Genital Herpes Treatment DrugProduct
Table 96. Admedus Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 97. Admedus Recent Development
Table 98. Sanofi Pasteur SA Company Detail
Table 99. Sanofi Pasteur SA Business Overview
Table 100. Sanofi Pasteur SA Genital Herpes Treatment DrugProduct
Table 101. Sanofi Pasteur SA Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 102. Sanofi Pasteur SA Recent Development
Table 103. Maruho Co. Ltd. Company Detail
Table 104. Maruho Co. Ltd. Business Overview
Table 105. Maruho Co. Ltd. Genital Herpes Treatment DrugProduct
Table 106. Maruho Co. Ltd. Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 107. Maruho Co. Ltd. Recent Development
Table 108. F.Hoffmann-La Roche Ltd. Company Detail
Table 109. F.Hoffmann-La Roche Ltd. Business Overview
Table 110. F.Hoffmann-La Roche Ltd. Genital Herpes Treatment DrugProduct
Table 111. F.Hoffmann-La Roche Ltd. Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 112. F.Hoffmann-La Roche Ltd. Recent Development
Table 113. Novartis AG Company Detail
Table 114. Novartis AG Business Overview
Table 115. Novartis AG Genital Herpes Treatment DrugProduct
Table 116. Novartis AG Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 117. Novartis AG Recent Development
Table 118. Merck & Co. Inc. Company Detail
Table 119. Merck & Co. Inc. Business Overview
Table 120. Merck & Co. Inc. Genital Herpes Treatment DrugProduct
Table 121. Merck & Co. Inc. Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 122. Merck & Co. Inc. Recent Development
Table 123. GlaxoSmithKline Plc Company Detail
Table 124. GlaxoSmithKline Plc Business Overview
Table 125. GlaxoSmithKline Plc Genital Herpes Treatment DrugProduct
Table 126. GlaxoSmithKline Plc Revenue in Genital Herpes Treatment Drug Business (2017-2022) & (US$ Million)
Table 127. GlaxoSmithKline Plc Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genital Herpes Treatment Drug Market Share by Type: 2021 VS 2028
Figure 2. Acyclovir (Zovirax) Features
Figure 3. Famciclovir (Famvir) Features
Figure 4. Valacyclovir (Valtrex) Features
Figure 5. Others Features
Figure 6. Global Genital Herpes Treatment Drug Market Share by Application in 2021 & 2028
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Genital Herpes Treatment Drug Report Years Considered
Figure 11. Global Genital Herpes Treatment Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Genital Herpes Treatment Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Genital Herpes Treatment Drug Market Share by Region: 2021 VS 2028
Figure 14. Global Genital Herpes Treatment Drug Market Share by Players in 2021
Figure 15. Global Top Genital Herpes Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Treatment Drug as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Genital Herpes Treatment Drug Revenue in 2021
Figure 17. North America Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Genital Herpes Treatment Drug Market Share by Country (2017-2028)
Figure 19. United States Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Genital Herpes Treatment Drug Market Share by Country (2017-2028)
Figure 23. Germany Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Genital Herpes Treatment Drug Market Share by Region (2017-2028)
Figure 31. China Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Genital Herpes Treatment Drug Market Share by Country (2017-2028)
Figure 39. Mexico Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Genital Herpes Treatment Drug Market Share by Country (2017-2028)
Figure 43. Turkey Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Genital Herpes Treatment Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Fresenius Kabi Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 46. Avet Pharmaceuticals Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 47. Carlsbad Tech Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 48. Glenmark Pharmaceuticals Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 49. Zydus Pharmaceuticals Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 50. Mylan Pharmaceutcials Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 51. Apotex Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 52. Epi Health LLC Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 53. AiCuris Anti-infective Cures GmbH Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 54. Chimerix Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 55. Admedus Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 56. Sanofi Pasteur SA Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 57. Maruho Co. Ltd. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 58. F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 59. Novartis AG Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 60. Merck & Co. Inc. Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 61. GlaxoSmithKline Plc Revenue Growth Rate in Genital Herpes Treatment Drug Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock